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ABSTRACT

PHENOTYPIC SCREENING AND CHARACTERIZATION OF PROTEINS WITH
UNKNOWN FUNCTION IN Streptococcus sanguinis SK36

By Ayana Scott-Elliston, B.S.

A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
at Virginia Commonwealth University.

Virginia Commonwealth University
Richmond, VA
May 2017

Principal Investigator: Dr. Peter Uetz
Associate Professor in the Center for Biological Complexity

With the number of fully sequenced bacterial genomes increasing in the past 7 years, it
has been discovered that a large percentage of the putative protein coding genes have no known
function. This lack of knowledge leaves scientists with an incomplete understanding of bacteria.
In this study, conserved hypothetical protein mutants from Streptococcus sanguinis SK36 were
screened on solid media with various environmental conditions. From these screens, the

VIII

candidate protein, SSA_2372, displayed a sensitivity to acidic conditions. Its homolog in
Bacillus subtilis 168, BSU00030, also displayed a sensitivity to pH conditions at its acid
tolerance extremes unlike its other homolog in Escherichia coli, YbcJ. When the growth rate and
cell yield was acquired, the sensitivity was shown to be significant for both SSA_2372 and
BSU00030 mutants. Through data mining, it was determined that Firmicutes in this homolog
family COG2501 may function as a regulator for recombination protein F.
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Chapter 1
Introduction
I.

Homology
The definition of homology is a heavily debated subject [1]. Homology has evolved with

the increase in genomic technology and computer advancements. Its origins involved scientists
such as Darwin and Owen, and these scientists defined homology based upon physical similarity
between anatomical appendages and organs of different species. Currently, its study determines
associations between organs and molecular machines based on genetics. A
general working definition of homology that I will be using is the similarity of structure and
function between species based on common descent.
Today, homology is largely interwoven with phylogeny, which is the study of
relationships in evolution. With this intersection of themes, new terminology was necessary;
some of these terms are orthologs, paralogs, and xenologs. Orthologs are homologs that are a
result of speciation and maintain the same function [2]. They may not have the same nucleic acid
and amino acid sequence, but the similarity exists in its final structure and general function.
Paralogs and xenologs are interrelated. When homology is the result of gene duplication and the
two genes evolved together within an organism, this homolog is termed a paralog [2]. A xenolog
is also a duplication of a gene; yet, the duplicate gene has been proven to be a gene transferred
by horizontal or lateral gene transfer (HGT) from a different species or from a subpopulation of
the same species [2].
The nineteenth-century morphologist Richard Owens defined homologs as "the same
organ in different animals under every variety of form and function" [2]. Genetic homology
utilizes sequence, structure, and function data from previous studies to predict potential
1

homologs between species. Owen's concept of homology can be applied to bacteria, and it will
be the utilized in this study. Specifically, I will apply the overall theme of homology based
on Owen, but I will use the techniques of genetic homology to find connections between proteins
[1].
II.

Uncharacterized Proteins
The number of fully sequenced bacterial genomes has increased exponentially in the past

7 years, but many of the putative proteins in these bacterial species have no known function [3].
Since Next Generation Sequencing (NGS) was developed, the number of fully sequenced
genomes has increased exponentially, and we have reaped benefit from this knowledge. For
characterized proteins, we know where in the genome they are located, which is advantageous
for drug targeting studies of pathogenic bacteria and for the study of human-microbe interactions
in health. For example, knowing the full sequence of prokaryotic genomes has allowed for
techniques such as CRISPR to be found and developed, which has allowed for targeted
mutagenesis and targeted disease treatment development.
Unfortunately, 25% to 60% of these proteomes are composed of proteins with unknown
function, also known as hypothetical or uncharacterized proteins [3]. Hypothetical proteins are
proteins that are predicted to be expressed from an open reading frame, but for which there is no
experimental evidence of translation from mRNA [4]. Based on computational analysis, these
hypothetical proteins often fit into important functional classes, such as hydrolases, transferases,
transporters, DNA binding proteins, and RNA binding proteins [3]. Having such a large
proportion of proteins with unknown function creates a gap in our understanding of these
organisms as biological systems alone and within a host system. Therefore, acquiring this
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knowledge could help to create more efficient treatments and to prevent unnecessary secondary
reactions that we observe in current treatments by understanding the protein pathways fully [5].
Among hypothetical proteins, there are proteins conserved among multiple organisms
from several phyla [4]. These proteins are called conserved hypothetical proteins and have no
functional validation. As of October 2014, GenBank labeled 48,591,211 hypothetical sequences
in NCBI, of which 34,064,553 were in bacteria [4]. Elucidating the function of one of these
proteins will not only annotate its own protein/gene dataset and supplement our knowledge of the
specific bacterium, but it will also provide functional information about its homologs.
III.

DNA
A. DNA Structure and DNA Damage
Deoxyribonucleic acid (DNA) serves as the genetic blueprint for all living creatures from

large mammals such as homo sapiens to microscopic bacteria. DNA is composed of two
antiparallel strands of covalently linked nucleotides [6]. Nucleotides have a nucleobase (adenine,
thymine, guanine, or cystosine), a monosaccharide, and a phosphate group, which forms the
covalent bond that establishes the sugar-phosphate backbone of DNA. The antiparallel strands of
DNA associate with each other by hydrogen bonds between the nucleobases. The
phosphodiester bond is one of the more kinetically stable bonds found in biological functional
groups [7]. DNA itself is stable at pH 7, and it can maintain its association in slightly alkaline
conditions (pH 8 to 9). The presence of sodium cations helps to increase the stability of DNA by
preventing the large negative charges of nucleophilic phosphate groups from destabilizing the
DNA.
Unfortunately, DNA has a susceptibility to drastic pH change, UV damage, and chemical
damage. UV and chemical damage cause double stranded breaks [8]. At low pH, the
3

phosphodiester bonds of the DNA's sugar phosphate backbone hydrolyze, and an increase in pH
above 9 causes the hydrolysis of the hydrogen bonds between the two antiparallel DNA
strands [9]. Fortunately, bacteria have developed repair mechanisms to combat the effects of
these environmental stressors.
B. DNA Repair
To combat environmental factors that damage DNA, such as UV damage and pH change, the
bacterial and eukaryotic cell has developed pathways to correct double stranded DNA damage.
Double stranded breaks are targets for exonucleases, which can lead to gene deletions,
to incorrect DNA ends connecting, and to chromosomal rearrangements that are commonly
present in tumors [8]. Bacteria, as well as eukaryotes, have developed two general pathways for
repair of double stranded DNA damage, which are non homologous end joining and homologous
recombination. Non homologous end joining (NHEJ) is the reconnection of the broken DNA
ends by the utilization of DNA ligase and of Ku [8]. Ku is a conserved protein that binds the
ends of the broken DNA strands to protect it from exonuclease degradation, and Ku recruits
DNA ligase to the break site to reform the bonds [8]. The second general pathway for remedying
double stranded DNA damage, homologous recombination, is performed for more difficult
breaks and has multiple stages that use multiple proteins in each stage.
Homologous recombination is composed of three stages: presynapsis, synapsis, and
postsynapsis, and the protein groups may vary depending on the bacterial phyla [10].
In presynapsis, 3' single stranded DNA ends are generated to bind with the homologous sequence
on the sister chromosome [8]. The proteins used in Escherichia coli for presynapsis is the
enzyme complex RecBCD (recombination protein BCD), which is a multifunction protein
complex with multiple domains [10]. Upon exposure to the Chi sequence signal
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(5'GCTGGTGG) on dsDNA, the recombination function of RecBCD is initiated, which causes
the enzyme to bind to DNA ends and to generate overhangs [8,10]. Synapsis presents the 3' DNA
overhang formed by RecBCD to the homologous duplex of the sister chromosome via the
enzyme Recombination Protein A (RecA) [8]. RecA requires ATP to bind to each ssDNA
overhang, to create a right handed helix for inserting into the homologous duplex DNA, and to
arbitrate annealing [8]. RecA has to be loaded onto the ssDNA due to Single Strand Binding
proteins having a higher affinity to ssDNA than RecA [8]. The loading of RecA onto the ssDNA
depends on the bacterial species. However, the RecFOR/FLOR pathway is conserved in many
species for that function. The RecFOR consists of proteins recombination protein F,
recombination protein O, and recombination protein R. For E.coli, the process is handled by one
of two epistatic groups, RecBCD or RecFOR[8]. Bacillus subtilis has five
epistatic groups, α (recFLOR and recN), β (addAB), γ (recP and recH) , ɛ (ruvA, recD,
and recU), and ζ (recS). During the final stage of homologous recombination, postsynapsis,
RecG and RuvA helicases generate a four stranded exchange, also known as Holliday junctions
[8].
IV. Acid Tolerance in Bacteria
Since DNA is essential to the function and propagation of all cells, the cell's ability to
maintain the stability of its DNA is paramount. In the gut microbiome the pH can range
drastically from 6.3 to 1.5, which is a million fold increase in the hydrogen proton concentration.
Subsequently, the bacterial cell has developed methods to maintain its intracellular pH despite
the drastic changes in its biome’s pH. Two examples of the bacterial cell's ability to maintain
internal pH is E.coli and B. subtilis, neutrophiles. E.coli can maintain an internal pH range of 7.2
to 7.8 in an extracellular pH range of 5.5 to 9, and B. subtilis, a neutrophile, can maintain a
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constant pH of 7.4 at the pH range of 6 to 8 [11]. The protective mechanisms that allow these
bacteria the capability to stabilize are distinguished into 2 categories XAR (extreme acid
resistance) and ATR (acid tolerance response). ATR mechanisms are adaptive responses at
nonlethal mildly acidic pH, such as pH 5.5 for E.coli K12, that enhances the bacteria's ability to
handle severe acidic challenge as low as pH 3 [11]. Most bacteria possess one ATR based
mechanism. XAR mechanisms allow cells that have not had the opportunity to acclimate to
their acidic conditions survive at pH conditions less than 2.5 [11]. An environment with such an
extreme high concentration of protons produces a biome that does not permit the growth
of neutrophilic bacteria.
VI. Streptococcus sanguinis
The oral ecosystem is a complex biome. The temperature is maintained around 35°C - 36
°C, except in inflammation induced conditions where it increases to 39 °C [12]. The majority of
the bacterial species in the mouth are facultative anaerobes or obligate anaerobes, yet there is a
small population of aerobes in the oral cavity [12]. The difference between the two types of
anaerobes is that facultative anaerobes can exist with or without oxygen present, where obligate
anaerobes cannot exist with oxygen. These oral microflora proliferate in distinct regions of the
mouth depending on their capability of handling various percentages of oxygen [12]. The most
anterior portion of the mouth is exposed to ~20% O 2, and the most posterior buccal folds is
~0.3%. Additionally, the oral cavity ranges distinctly in pH over time and in different regions,
which its inhabitants need to handle. A healthy mouth’s pH lies between 6.5 to 6.9 at rest, and as
a mouth is stimulated while eating its pH increases to between 7.0 to 7.5 [12]. The maintenance
of this pH is handled on regions of the mouth by saliva [12]. An individual with poor oral health
and dental caries tends to have a more acidic pH in their mouth. Normally, after the consumption
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of foods high in carbohydrates, the catabolism of sugars by the bacteria will decrease the pH.
However, the pH will return gradually to resting conditions [12]. The bacteria associated with
good oral health can handle brief instances of high concentrations of hydrogen protons, but the
bacteria associated with dental caries thrive in acidic conditions for a prolonged period of time.
One of these healthy oral microbes is Streptococcus sanguinis. It is a facultative
anaerobe, and its pH growth range in the mouth under normal conditions is from 5.0 to 7.8. S.
sanguinis inhibits the growth of bacteria involved in dental caries, e.g. Streptococcus mutans by
the release of hydrogen peroxide - an end product of its metabolism [12].
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VII. Research Objective
The Aims of this Study are:
1. To phenotypically screen conserved uncharacterized proteins of Streptococcus
sanguinis SK36
2.

To find a single protein without paralog that displays a phenotype to one of the
environmental conditions

3. To study the protein using bioinformatics, systems biology, and molecular biology to
potentially elucidate its function.
The overall objective of this study is to investigate and to characterize a conserved
uncharacterized protein family to help in the effort of closing our gap in knowledge of bacterial
proteins.
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Chapter 2
Materials and Methods
Bacterial Culture Conditions. The Streptococcus sanguinis SK36 wild type and its mutants
used in this study were created and provided by the Ping Xu Lab [13]. They are listed in Table 1.
S. sanguinis SK36 and its mutants were revived from 80% glycerol freezer samples in Brain
Heart Infusion Broth (BD Difco) broth under microaerophilic conditions (7 – 10% CO2 and 6%
O2) at 37 °C in an AnaeroPack 2.5 L Rectangular Jar (Thermo Scientific). For all experiments, S.
sanguinis SK36 and its mutants were grown in microaerophilic conditions (7 – 10% CO2 and 6%
O2) at 37 °C.
B. subtilis 168 and E.coli K-12 wild type and mutants used in this study are listed in
Table 2. B. subtilis 00030 mutant was provided by the Bacillus Genetic Stock Center, and E.coli
ybcJ mutant and oxaC control strain was provided by the Osterman lab at Sanford Burnham
Prebys Medical Discovery Institute. The Bacillus subtilis 168 WT, B. subtilis 168 00030 mutant,
Eschericihia coli K-12 WT, and E. coli K-12 ybcJ mutant were revived in LB broth in aerobic
conditions with 1 ug/mL erythromycin (B. subtilis) and 1 ug/mL kanamycin (E.coli).

Broth Preparation: Brain Heart Infusion. 37 grams of BHI powder was dissolved in 1000mL
deionized H2O using a stir bar and heating at 100 °C on a hot plate. It was then autoclaved for 15
minutes at 121°C. The sealed autoclaved broth was stored at 4 °C when not in use.
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Broth Preparation: pH specific BHI media. 37g of BHI powder was dissolved in 1000mL
deionized H2O using a stir bar and heating at 100 °C. The dissolved BHI broth was adjusted to
the following pH values depending on the experiment: 4, 5, 5.5, 6, 6.5, 7, 8, & 10. The pH
adjustments to create the acidic pH values were achieved by pipetting 12.1 M hydrochloric acid
until the broth reached the appropriate value. The alkaline pH values were reached by pipetting
volumes of 0.0316M NaOH (pH 12.5) into the BHI broth and mixing after each addition. When
the BHI was at the appropriate value, the Erlenmeyer flasks were autoclaved for 15 minutes at
121°C.

Agar Preparation: pH specific BHI plates. 52g of BHI agar powder was dissolved in 1000mL
deionized H2O using a stir bar and heating at 100 °C. The dissolved BHI broth was adjusted to
the following pH values depending on the experiment: 4, 5, 5.5, 6, 6.5, 7, 8, & 10. The pH
adjustments to create the acidic pH values was achieved by pipetting 12.1 M hydrochloric acid
until the broth reached the appropriate value. The alkaline pH values were reached by pipetting
volumes of 0.0316M NaOH (pH 12.5) into the BHI broth and mixing after each addition. When
the BHI was at the appropriate value, the Erlenmeyer flasks were autoclaved for 15 minutes at
121°C. When the Erlenmeyer flasks reached 70 °C, the molten agar was poured into omnitrays.
Once the plate solidified, it was stored in sterile containers in a cold room until used.

Agar Preparation: Chemically Defined Media with Various Sugars. All of the values of the
Chemically Defined Media used in Ping Xu’s study had to be doubled because it would be
diluted in half when the agar was introduced [13]. For every 1000 mL deionized H2O, 20g of
selected sugar, 4.0 g of L-glutamic acid, 0.4 g of L-cysteine, 1.8 g of L-leucine, 2.0 g of NH4Cl,
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5.0 g of K2HPO4, 5.0 g of KH2PO4, 8.0 g of NaHCO 3, 2.4 g of MgSO4.7H2O, 0.04 g of
MnCl2.4H2O, 0.04 g of FeSO4.7H2O, 1.2 g of sodium pyruvate, 2.0 mg of riboflavin, 1.0 mg of
thiamine HCl, 0.2 mg of D-biotin, 2.0 mg of nicotinic acid, 0.2 mg of p-aminobenzoic acid, 1.0
mg of Ca-pantothenate, 2.0 mg of pyridoxal HCl, 0.2 mg of folic acid, and adjusted to pH 7.0
with H3PO4. In order to add the sugar, riboflavin, thiamine HCl, D-biotin, nicotinic acid, paminobenzoic acid, Ca-pantothenate, pyridoxal HCl, and folic acid, a stock solution of each was
created with dH2O. Then, the appropriate volume from each stock solution was added to the
1000 mL solution. Once all of chemicals were added, the solution was filter sterilized with
Stericup filter bottle Units (Millipore). The selected sugars were glucose, mannose, galactose,
and lactose. The agar was made by adding 15g of agar to 1000mL dH2O, which was autoclaved
at 121 °C for 15 minutes. The agar was cooled in a hot water bath to 55 °C, which is lower than
the 60 °C degradation temp for the vitamins and the minimum temperature to maintain the liquid
phase of agar without bubbles.

Phenotype Screen: Solid Phase. Following the revival of the strains in a 96 well microtiter
plate, these mutants were pinned to the respective agar plate using a pin tool attached to the
Biomek FX robot (Beckman Coulter). The motion of the pin tool followed the respective
program I designed, and between pinning a new plate, it always included a four-step wash
process – a dH2O rinse, a 10 second ethanol soak, a 30 second 10% bleach soak, and a final
dH2O rinse. These plates were incubated for 48 hours in an Anoxomat jar (Spiral Biotech) in
which the microaerophilic conditions were generated by the Anoxomat system (Mart).

11

Quantification of Phenotype: Liquid Phase. 200µL of the BHI broth of a specific pH value
was added to the appropriate column in a black 96 well plate. For the S. sanguinis SK36 mutant
phenotype quantification, the wells were inoculated from an overnight growth by the pintool of
the Biomek FX robot. For the E.coli and B. subtilis strains phenotype quantification, the wells
were inoculated with 1 µL from an overnight growth. For both quantification studies, the source
plate mutants had an OD of 0.9 to 1.0 at 600 nm. The inoculum was grown overnight at 37 °C
with atmospheric conditions of 6% O2 and 6% CO2 in the BioTek Synergy H1 Hybrid MultiMode Monochromator Fluorescence Microplate Reader (BioTek). Readings were taken every
ten minutes at 600nm.

Bioinformatics. The sequence analysis and homolog search was performed using NCBI Protein
Blast non redundant protein sequences database; homolog determination was also performed via
Eggnog v 4.5.1 and UNIPROT [14,27]. The comparative multiple sequence alignment of the
COG2501 homologs were performed with ClustalOmega version 1.2.1 [15]. The visualization of
the phylogenetic tree data was created using the interactive Tree of Life (iTOL) version 3.5, and
the code utilized to separate the species from EGGNOG into families with stars was created by
Harry Caufield [16]. Protein abundance data was extracted on COG2501 from PaxDB version
4.0 [17]. The source of the data was either presented in the file extracted from the website, or it
was acquired by contacting the PaxDB curators [17]. Hypothetical COG2501 structures and
secondary structure information was calculated by I-Tasser version 5.1 and RaptorX [18,19, 20,
21]. The NCBI taxonomy database was utilized for information on phyla [22], and the Microbial
Genome Context Viewer (MGcV) was used to visualize the genome context for all proteins in
this study [29].
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Statistics, Growth Rate, & Doubling Time Calculations.
All statistical tests were performed utilizing R and R Studio [23,24]. The necessary packages for
these statistical tests were stats version 3.3.2, methods version 3.3.2, datasets version 3.3.2, and
utils version 3.3.2. The R code used is in the Supplemental (Supplemental Table 2). Exponential
growth rate is a first order reaction, and the equation used to calculate the growth rates and
doubling times are below. In the growth rate equation, t represents time, and c represents the
optical density obtained at 600nm.
K = growth rate = ln (Cf/Ci)
(tf – ti)
t2/1 = doubling time = ln (2)
k
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Table 1: S. sanguinis strain and its mutants without paralogs used in this study
Conserved hypothetical
protein mutants
SK36 wildtype

Mutation

SSX_0064

SSA_0064 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0066 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0073 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0101 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0152 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0161 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0183 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0188 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0224 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0238 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0252 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0273 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0274 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0281 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0288 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0293 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0299 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0305 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0311 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0316 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0339 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0341 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0353 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method

SSX_0066
SSX_0073
SSX_0101
SSX_0152
SSX_0161
SSX_0183
SSX_0188
SSX_0224
SSX_0238
SSX_0252
SSX_0273
SSX_0274
SSX_0281
SSX_0288
SSX_0293
SSX_0299
SSX_0305
SSX_0311
SSX_0316
SSX_0339
SSX_0341
SSX_0353

Species
Count

14

157
217
280
530
7
15
67
582
23
66
26
9
120
13
2
1073
376
77
186
917
284
507
74

SSX_0354
SSX_0390
SSX_0431
SSX_0446
SSX_0505
SSX_0591
SSX_0595
SSX_0624
SSX_0627
SSX_0629
SSX_0646
SSX_0647
SSX_0659
SSX_0664
SSX_0668
SSX_0670
SSX_0672
SSX_0711
SSX_0752
SSX_0755
SSX_0802
SSX_0803
SSX_0815
SSX_0843
SSX_0844
SSX_0864

SSA_0354 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0390 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0431 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0446 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0505 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0591 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0595 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0624 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0627 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0629 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0646 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0647 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0659 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0664 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0668 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0670 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0672 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0711 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0752 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0755 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0802 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0803 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0815 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0843 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0844 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0864 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
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62
142
256
117
70
312
540
1499
182
239
96
157
438
79
205
89
1599
411
692
121
749
130
323
664
93
464

SSX_0868
SSX_0874
SSX_0885
SSX_0915
SSX_0978
SSX_0983
SSX_0985
SSX_0990
SSX_0992
SSX_1067
SSX_1076
SSX_1078
SSX_1083
SSX_1154
SSX_1156
SSX_1161
SSX_1180
SSX_1201
SSX_1203
SSX_1211
SSX_1214
SSX_1238
SSX_1247
SSX_1248
SSX_1249
SSX_1280

SSA_0868 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0874 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0885 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0915 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0978 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0983 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0985 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0990 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_0992 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1067 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1076 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1078 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1083 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1154 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1156 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1161 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1180 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1201 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1203 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1211 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1214 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1238 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1247 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1248 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1249 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1280 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
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1303
736
108
58
169
55
108
114
77
64
321
121
75
996
80
173
139
1506
200
136
109
95
80
74
95
341

SSX_1313
SSX_1348
SSX_1353
SSX_1384
SSX_1404
SSX_1418
SSX_1439
SSX_1454
SSX_1455
SSX_1471
SSX_1480
SSX_1526
SSX_1535
SSX_1537
SSX_1540
SSX_1545
SSX_1549
SSX_1554
SSX_1562
SSX_1585
SSX_1586
SSX_1587
SSX_1610
SSX_1618
SSX_1627
SSX_1646

SSA_1313 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1348 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1353 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1384 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1404 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1418 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1439 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1454 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1455 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1471 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1480 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1526 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1535 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1537 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1540 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1545 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1549 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1554 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1562 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1585 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1586 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1587 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1610 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1618 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1627 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1646 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
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191
78
303
78
59
495
932
60
215
729
256
360
66
177
67
112
302
83
552
343
327
338
149
594
302
226

SSX_1651
SSX_1686
SSX_1704
SSX_1707
SSX_1746
SSX_1765
SSX_1770
SSX_1772
SSX_1786
SSX_1808
SSX_1817
SSX_1833
SSX_1837
SSX_1844
SSX_1855
SSX_1899
SSX_1910
SSX_1911
SSX_1921
SSX_1941
SSX_1960
SSX_1981
SSX_1987
SSX_2000
SSX_2013
SSX_2021

SSA_1651 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1686 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1704 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1707 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1746 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1765 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1770 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1772 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1786 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1808 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1817 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1833 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1837 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1844 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1855 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1899 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1910 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1911 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1921 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1941 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1960 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1981 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_1987 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2000 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2013 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2021 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
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69
129
137
75
51
94
593
169
207
83
98
47
1126
98
998
404
346
1076
53
234
92
75
176
85
118
69

SSX_2030
SSX_2036
SSX_2038
SSX_2076
SSX_2126
SSX_2170
SSX_2188
SSX_2189
SSX_2198
SSX_2252
SSX_2337
SSX_2340
SSX_2354
SSX_2369
SSX_2372
SSX_2386
SSX_2390
SSX_2390

SSA_2030 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2036 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2038 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2076 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2126 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2170 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2188 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2189 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2198 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2252 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2337 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2340 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2354 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2369 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2372 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2386 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2390 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method
SSA_2390 replaced with aphA- 3 gene encoding kanamycin
resistance using recombinant PCR method

Table 2: B.subtilis & E.coli strains and COG2501 homologs used in this study.
Bacterial Strain

Strain Mutant

B. Subtilis 168

yaaA, BKE00030

E. coli K-12

ybcJ, b0528, JW5070

E. coli K-12

uxaC
19

1272
241
150
139
1653
278
361
269
52
218
78
130
283
277
184
52
377
1653

Chapter 3
Environmental Based Screening of 149 S. sanguinis SK36 mutants & the
Candidate Proteins that were Found
Identification of Candidate Protein
The qualitative rate of growth of 147 S. sanguinis SK36 mutants in different pH
conditions (pH 5.8, pH 6, pH 7, pH 8, & pH 10) was analyzed based on the diameter of the
inoculation pin on BHI agar. All of the selected mutants grew with diameters the size of the pins
at pH 7, which was our pH control for growth (Figure S1). At slightly acidic pH of 6, the mutant
in row D column 9, SSX_2372, had diminished growth (Figure 1). When you zoom into row D,
you can see the mutants in columns 1 to 8 have full pins in which you unable to distinguish
individual colonies from the pin (Figure 2). SSX_2372 was not affected by a change in carbon
source, and it grew the same with glucose, mannose, lactose and galactose (Figure 3, 4, 5, 6). All
colonies grew to the same size (Figure 3, 4, 5, 6).
To get a clearer visual comparison of the two candidate proteins SSA_2372 &
SSA_1480, the two candidate proteins were pinned to agar alongside the wildtype and two pH
control mutants, SSX_0204 and SSX_1507 (Figure 7). These pH control mutants were identified
in previous studies by the Xu lab. SSX_0204 has an acid resistant phenotype, and SSX_1507 is
acid sensitive. At pH 7, SSX_1507 has a diminished diameter of its inoculation pin, and its
individual colonies are visible (Figure 7). SSX_1507 has no growth at pH 7 (Figure 7). These
mutants were discovered to have these phenotypes in Dr. Ping Xu’s lab [13]. When compared to
S. sanguinis SK36 pH control mutants, SSX_2372 has pronounced pH phenotype (Figure 7).
SSX_2372 at pH 6 looks like SSX_1507 does at pH 7 (Figure 7). You can see individual
colonies, and the diameter of the inoculation pin is smaller (Figure 7).
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Figure 1. BHI Agar Plate (pH6) Pinned with Streptococcus sanguinis SK36 mutants. On
these two plates, 95 mutants were pinned in quadruplicate, and the plate was incubated at 37 °C
under microaerophilic conditions for 48 hours. The dotted box indicates the wells with extreme
diminished growth.
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Figure 2. BHI Agar Plate (pH 6) Pinned with Streptococcus sanguinis SK36 mutants Zoom
Into Candidate Protein, SSA_2372. On these two plates, 95 mutants were pinned in
quadruplicate, and the plate was incubated at 37 °C under microaerophilic conditions for 48
hours. Row D was enlarged to make the well, D9, that displayed the acid sensitivity clear.
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Figure 3. Chemically Defined Agar with Glucose. This plate contains the minimal amount of
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for
this plate is glucose. It was grown at 37 °C for 48 hours under microaerophilic conditions.
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Figure 4. Chemically Defined Agar with Lactose. This plate contains the minimal amount of
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for
this plate is lactose. It was grown at 37 °C for 48 hours under microaerophilic conditions.
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Figure 5. Chemically Defined Agar with Mannose. This plate contains the minimal amount of
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for
this plate is mannose. It was grown at 37 °C for 48 hours under microaerophilic conditions.
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Figure 6. Chemically Defined Agar with Galactose. This plate contains the minimal amount of
nutrients necessary for a S. sanguinis SK36 bacterium to survive. The selected carbon source for
this plate is galactose. It was grown at 37 °C for 48 hours under microaerophilic conditions.
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Figure 7. Qualitative Comparison at pH 6 and pH 7 of Streptococcus sanguinis SK 36
candidate mutants and control mutants on BHI Agar. The plates were pinned using a Biomek
FX with a pin plate in quadruplicate for each mutant in BHI agar at pH 7 and pH 6. These plates
were grown at 37 °C under microaerophilic conditions.
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Quantification of Phenotype
The candidate proteins’ cell yield was quantified and compared using optical density in a
96 well plate at pH 4, pH 5.8, pH 6, pH 7, pH8, and pH 10 in BHI broth (Figure 8). The doubling
time of S. sanguinis SK36 wildtype is approximately 1 hr 11 minutes under microaerophilic
conditions at pH 7, and it has a growth rate of 0.58 doublings per hour. At pH 6, S. sanguinis
SK36 wildtype has a doubling time of 3 hours and 10 minutes. The acid sensitive control mutant,
SSX_1507, grew the least at pH 7 as expected based on its growth on the agar, and it had
negligible growth at pH 6 (Figure 8). The doubling time of SSX_1507 at pH 7 is approximately 1
hour 41 minutes, and its growth rate is 0.4 doublings per hour. The doubling time of SSX_1507
at pH 6 was 0.076 doublings per hour, and it had a doubling time of approximately 9 hours.
SSX_1507’s cell yield and growth rate are significantly different at a p value of 0.01 and 0.05 at
both pH 6 and pH 7 than the wildtype of S. sanguinis SK36, which makes it a good acid sensitive
control. The candidate mutant, SSX_2372, has a cell yield that is significantly smaller compared
to the wildtype at confidence level of 95% and 99% at pH 7 and pH 6. SSX_2372 has a growth
rate of 0.16 doublings per hour and a doubling time of approximately 4 hours and 18 minutes.

28

Figure 8. Growth Curves of the S. sanguinis SK36 candidate mutants and control mutants
in BHI broth at pH 7 and pH 6. 96 well plates were inoculated in pH specific media, and it was
grown overnight under microaerophilic conditions. Optical density readings at 600nm were
recorded every 10 minutes.
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Chapter 4
Bioinformatic Characterization of S. sanguinis SSA_2372 Protein & the
Analysis of its Conserved Orthologous Group, COG2501

Conservation of COG2501
The conservation of this candidate protein was determined utilizing bioinformatics
databases. COG2501 can be found in 776 species of bacteria (16 ). Homologs of SSA_2372 can
be found in 5 major phyla and 2 superphyla (Figure 9). The phyla include Proteobacteria,
Firmicutes, Actinobacteria, Cyanobacteria, and Fusobacteria, and the superphyla include PVC
group and FCB Group (Figure 9). Homologs of COG2501 in the PVC superphyla can be found
in Ilyobacter (order), unclassified Verrucomicrobiales (order), and Planctomycetaceae (family),
and in the FCB group they are found in Flavobacteriales (order) and Sphingobacteriales (order)
(Figure 9). Homologs are not found in the phyla of Chlamydiae, Thermodesulfobacteria,
Acidobacteria, Thermotogae, and Spirochaetes, and Chloroflexi (Figure 9). In the phyla,
homologs are found in 33 families of Firmicutes, 85 families of Proteobacteria, 26 families of
Actinobacteria, and 2 families and 3 orders of Cyanobacteria.
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Figure 9. Phylogenetic Tree displaying the conservation of COG2501 at the phyla and
superphyla level. Homolog list with NCBI identifiers was extracted from the EGGNOG
database, and the dataset was inputted into iTOL v3.5 for phylogenetic tree visualization.

31

Functional Annotation, Expression, and Structural Prediction of SSA_2372
In depth data mining and utilization of structural genome prediction software was
performed to gather functional and structural information on this gene/protein family. Based on
NCBI protein blast comparisons and other various protein comparison software, SSA_2372 has
been established as having an S4 domain (Table 3) [25]. It has two domains: a conserved
domain, S4, and a coil-coil domain. The S4 domain is approximately 64 AA in length, and it is
predicted to be comprised of 3 alpha helices and 5 beta sheets (Table 3). The S4 domain is also a
part of a well conserved domain family [25]. The coil-coil domain is a non-conserved domain
family, and it is predicted to be composed of alpha helices in a scissor shape. The RaptorX
structure prediction, which is a software that predicts structure on sequence alone, has 3 alpha
helices and 5 beta sheets (Figure 10) [20]. I-Tasser, which utilizes both sequence and crystal
structures from homologs, also has 3 also has 3 alpha helices and 5 beta sheets (Figure 12). In
RaptorX, the coil-coil domain, curls towards the other domain forming a pocket (Figure 11).
However, in I-Tasser, the coil-coil domain extends away from the S4 domain (Figure 12).
The protein expression level of COG2501 depends on the species. The Streptococcus
pyogenes homolog (Firmicute), SPY_2203, expresses under normal BHI conditions at 5.11 ppm
and 9.69 ppm (Table 4). When the growth media is supplemented with 0.3% yeast, it expresses
at a slightly higher value of 31.5 ppm (Table 6). When compared to the expression of all proteins
in S. pyogenes, it is in the bottom 10% to 25% (Table 4). The E.coli homolog (Proteobacteria)
YbcJ, expresses under various growth conditions in the top 25%. Some of the abundance values
are 805 ppm, 617 ppm, and 352 ppm (Table 4).
Genomic Context and Sequence Comparison of COG2501
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COG2501 varies both in sequence similarity and in size from a single domain protein
approximately 68 AA to 80 AA in length to a two-domain protein approximately 130 to 140 AA
in length (Figure 10, 13, 14). In all species of the genus Streptococcus, COG2501 has two
domains and is approximately 130 AA in length. In all homologs in the genus Lactococcus,
COG2501 also has two domains and is ~130 AA in length (Figure 10). In Bacillus homologs
such as B. subtilis, the protein only has a single domain and is 70 AA in length, which is the S4
domain (Figure 10). B. subtilis has a sequence similarity of ~60% (Figure 13). For all other
homologs such E. coli and V. cholera, the protein is ~70 AA in length with the single predicted
S4 domain (Figure 10). E.coli has a sequence similarity of ~ 20% (Figure 14). The
Streptococcus, Lactococcus, and Bacillus genus is in the Firmicutes phyla, and E.coli is in
Proteobacteria [22].
Interactions of COG2501
The interactions of COG2501 family of proteins depends on the species. In E.coli, YbcJ
interacts with the subunits of the ribosome, 30S ribosomal proteins and 50S ribosomal proteins,
but not the polysome (26). This data was determined by pull down assays and immunoblot
analysis [25, 28]. These ribosomal subunits include: 30S ribosomal protein S6, 30S ribosomal
protein S2, 30S ribosomal protein S3, 50S ribosomal protein L1, 50S ribosomal protein L7/L12,
50S ribosomal protein L9, 50S ribosomal protein L11, 50S ribosomal protein L19, 50S
ribosomal protein L20, and 50S ribosomal protein L33 (Table 4). ybcJ also interacts with
metabolic enzymes and degradation proteins. It interacts with Pnp-polyribonucleotide
nucleotidyltransferase, aceF- dihydrolipoyllsine-residue acetytyltransferase component of
pyruvate dehydrogenase complex, dnaJ- chaperone protein DnaJ, and Eno – alpha-enolase
(Table 4). Pnp is involved in mRNA degradation and tRNA processing; it catalyzes the
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phosphoroylsis of ss polyribonulceotides in the 3’ to 5’ direction and works with RNase II (Table
4). AceF catalyzes the conversion of pyruvate to acetyl-CoA and oxygen, and DnaJ works with 2
other proteins to disaggregate stress-denatured and unfolded proteins [27]. The S. pneumoniae
homolog, SP_2226, was found to interact by Y2H in the Uetz lab with SP_0064 - PTS system
IIA component – and by microfluidics with SP_2227 – recombination protein F.
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Table 3. Annotation of SSA_2372 from NCBI & UNIPROT.
SSA_2372 Annotation
Sequence
Domains

MEYKLFDDYITLQALLKETGIIQSGGAIKTFLSEYPVLFNGEPENRRGKKLR
VNDRISLPEQGIEINLTAPSQEEILQHQKEIAEKKRVAELVKAMNKDLKKSQ
TSKKEKRKNTGIPKKQKTTKSPVRFPGI
S4 Domain
Coil-coil
Approximately 64 AA in length

Approximately 30 AA in length

3 alpha helices and 5 beta sheets

Alpha helices in scissor shape

Conserved domain

Non-conserved domain

EGGNOG

COG2501

NCBI

YP_001036279.1

UNIPROT

A3CRC4
No identical proteins outside of Streptococcus sanguinis
Found in all sequenced strains of Streptococcus sanguinis
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Figure 10. Structural rendering of SSA_2372 using RaptorX. RaptorX developed this 3-D
rendering based on the sequence alone using its in house developed software.
36

Figure 11. Structural rendering of SSA_2372 using iTasser. iTasser developed this 3-D
rendering for SSA_2372 using it sequence and homolog modeling. In the S4 protien family,
there currently are only 3 crystal structures in PDB: ybcJ, S4, and tyrosyl-tRNA synthetase.
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Figure 12. Genomic context of SSA_2372 and its homologs created using MgCV. NCBI
locus tags were extracted from UNIPROT and EGGNOG, and these locus tags were used in
MGcV to visualize SSA_2372 and COG2501 homologs in the context of their position in their
respective genomes. SSA_2372 and the COG2501 homologs are framed in red.
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Figure 13. Sequence alignment of SSA_2372 of S. sanguinis and yAAA of B.subtilis. The
sequences were acquired from NCBI, and the sequence comparison was done using ClustalW.

Figure 14. Sequence alignment of SSA_2372 of S. sanguinis and ybcJ of E. coli. The
sequences were acquired from NCBI, and the sequence comparison was done using ClustalW.
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Table 4. Annotation of SSA_2372 from NCBI & UNIPROT.
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Table 5. Experimentally Confirmed Interactions of SSA_2372 Firmicute homologs:
SP_2226, (S. pneumoniae), SP_2100 (S. pneumoniae), and BSU11620 (B. subtilis)
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Table 6. Protein Abundance of COG2501 homologs extracted from PaxDB.
Protein Abundance
Gene

PPM

Percentage in the Entire Proteome of

Name
ybcJ

Spy_2203

that extraction
805 ppm

Top 25%

617 ppm

Top 25%

352 ppm

Top 25%

331 ppm

Top 25%

5.11 ppm

Bottom 10%

9.69 ppm

Bottom 10%

31.5 ppm

Bottom 25%
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Chapter 5
Phenotype Comparison of 2 homologs of SSA_2372: BSU00030 in B. subtilis
and ybcJ in E.coli

To determine if the acid sensitivity phenotype was SSA_2372 specific, strains with
mutations in two homologs, YbcJ and BSU00030, were grown in pH increments of 0.5 within
the range of pH 5 – 8. At pH 7 and pH 6, BSU00030 had no significant difference in growth rate
or cell yield to the B. subtilis WT (Figure 15). However at pH 5.5 and pH 5, BSU00030’s cell
yield was significantly different from B.subtilis WT (Figure 16). In the cases where the mutant
was significantly different from the WT, it was the mutant that had significantly smaller cell
yield. E. coli had different results. There was no significant difference at pH 7 between the
control and the YbcJ mutant (Figure 17). At pH 6, there was a significant difference between
control and YbcJ mutant, but in this case it was the control E.coli mutant, oxaC gene knockout,
that had a significantly smaller cell yield compared to the COG2501 homolog, YbcJ. At pH 5,
however, there was no significant difference between the YbcJ mutant and the control mutant in
cell yield or growth rate (Figure 18).
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Figure 15. Quantification of Acid Tolerance Phenotype in B. subtilis WT and BSU00030 at
pH 6 and 7. 96 well black walled plates had media containing BHI media of the following pH
range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at 600nm of the WT and
BSU00030 was recorded every 10 minutes for 20 hours. This graph shows the comparison of the
growth values at pH 7 and pH 6. With a 95% confidence level, the p-value for a two sided t-test
between the WT and the mutant at pH 6 is 0.899, which is not significant.
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Figure 16. Quantification of Acid Tolerance Phenotype in B. subtilis WT and BSU00030 at
pH 5 and 7. 96 well black walled plates had media containing BHI media of the following pH
range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at 600nm of the WT and
respective mutant was recorded every 10 minutes for 20 hours. This graph shows the comparison
of the growth values at pH 7 and pH 5. With a 95% confidence level, the p-value for a two sided
t-test of the WT and mutant at pH 5 is 5E-9, which is significant.
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Figure 17. Quantification of Acid Tolerance Phenotype in E.coli oxaC kanamycin cassette
control and ybcJ at pH 6 and 7. 96 well black walled plates had media containing BHI media
of the following pH range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at
600nm of the WT and respective mutant was recorded every 10 minutes for 20 hours. This graph
shows the comparison of the growth values at pH 7 and pH 6. With a 95% confidence level, the
p-value for a two sided t-test between the control and the mutant at pH 6 is 0.002968, which is
significant.
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Figure 18. Quantification of Acid Tolerance Phenotype in E.coli oxaC kanamycin casette
control and ybcJ at pH 5 and 7. 96 well black walled plates had media containing BHI media
of the following pH range: 5, 5.5., 6, 6.5, 7, and 8. In separate experiments, the OD value at
600nm of the WT and respective mutant was recorded every 10 minutes for 20 hours. This graph
shows the comparison of the growth values at pH 7 and pH 5. With a 95% confidence level, the
p-value for a two sided t-test between the control and the mutant at pH 5 is 0.2896, which is not
significant.
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Chapter 6
Discussion

Screening mutants based on phenotypic features provides pertinent information that can
be immediately annotated to its COG or ENOG; however, if you desire perspective on the
bacteria's behavior in its natural environment, you must select your phenotype choice carefully.
For our phenotypic screens, I selected different pH ranges and sugars as the natural biome of S.
sanguinis SK36 is the mouth, which is exposed to different metabolites and pH ranges regularly.
With these two types of screens, we could easily detect the impact to the mutants, and draw
relevant conclusions. In the oral microbiome, pH decreases as a result of the metabolism of the
native bacteria; it will also vary due to the pH of the items consumed, whether being acidic or
alkaline. An individual's diet, which depending on your geographic region can be very specific,
dictates the exposure to simple sugars that your oral microbiome experiences. For example, we
used mannose as one of the screening sugars, which can be found in tomatoes, apples, oranges,
and cranberries. If these foods aren't common in your environment, your bacteria may not have
developed a pathway to process it, or it may exist as a non-essential pathway that was developed
in early homo sapiens. In the case of the study, we found more than one mutant that showed
susceptibility to low pH, such as SSA_1480, but none other with such a strong phenotype to low
pH as SSA_2372. The decision to focus on SSA_2372, otherwise known as COG2501, was
because the gene is conserved within multiple strains of S. sanguinis; it has a GC content similar
to most of its genome, demonstrating that it was not horizontally transferred; and because it is a
well conserved homolog in all phyla.

48

In deciding to perform phenotypic screening, one caution - that must be considered - is
whether the phenotype observed is directly related to the gene's function or is indirectly related
to the gene's function. The change in proton concentration intracellularly can impact various
processes from DNA replication to protein stability. Therefore, when a mutant shows a
phenotype of sensitivity to low pH, it cannot be assumed it is due directly to the protein's
function, but must consider it could be related to the protein's interactions with other proteins
that have a direct impact on intracellular pH maintenance or pH damage recovery systems. In the
case of COG_2501 homologs in the Firmicutes phyla, the protein itself is annotated as an RNA
binding protein based on similarity in sequence motif, but that should not alone have great
impact on maintenance of intracellular proton concentration or DNA damage. However, all
homologs in the Firmicutes phyla share an operon with recombination protein F, which is
necessary to repair DNA damage. Without the homologous recombination pathway of DNA
repair at a pH extreme to the particular bacteria, it will no longer be able to grow or survive. This
is an example of an indirectly related phenotype where it is the protein's interaction with another
protein that leads to the expression of a phenotype.
The method of screening, solid or liquid phase, can streamline your screening process.
For the oral microbiome, the majority of the screening is performed in liquid phase, which is
beneficial since it provides quantitative data immediately. However, performing the screening in
solid phase provides qualitative and physical data, which is extremely useful. The problem arises
when you try to do solid phase with chemically defined media. Certain vitamins degrade above a
temperature of 60 C. Therefore, I had to design a method to create solid phase chemically
defined agar plates. Agar remains in liquid phase until 55 C. Therefore, the flask has to be placed
in a hot water bath to maintain it at this temperature after autoclaving. The temperature sensitive
49

nutrients are added when the water bath temperature settles back to 55 C (Note: When you place
a container of a higher temperature in water, it will increase the temperature of the water
temporarily).
When using interaction network databases, the networks presented must be evaluated
carefully. For SSA_2372, the string database presents multiple functional partners including
DNA gyrase B, chromosomal initiation protein, DNA-directed RNA polymerase subunit delta,
and DNA polymerase III subunit beta. This network would suggest that SSA_2372 is involved in
DNA replication. The string database annotates it as being due to genomic context. However,
when you look at the genomic context for SSA_2372, it is only adjacent to recombination protein
F. When you continue data mining, it is discovered that the genes labeled as within the
neighborhood and as appearing concurrently appears only in the model organism, E. coli. Most
times the data presented in databases like String will be based on only one bacterium, but it will
present the data as if it were based on that particular species or genus. There needs to be better
contextual relationships presented for these networks, and actual interaction data should be
utilized such as from Intact or by data mining.
Based on the genomic context of S. sanguinis SK36 and a microfluidic experiment
performed by a collaborator (Meier et al), SSA_2372 is involved in some degree with the protein
recombination protein F. For all bacteria in the phyla Firmicutes, the homologs, COG2501, are
adjacent (2 to 5 AA apart) to recF. In a microchip array study with cDNA spotted in individual
wells, recF as a bait expressed in a well interacted with the SP_2226 (Streptococcus pneumoniae
TIGR4) protein solution. Since the cDNA is transcribed to RNA and translated to protein in the
well, there is a potential that the SP_2226 interacted with both the DNA/RNA and protein of
SP_2227, RecF.
50

Based on our data and the data mined, there is a great likelihood that our protein is a
transcription factor or regulator of recombination protein F. The reason that I believe it is a
regulator is because of its protein expression level. Proteins in the cytosol that bind RNA or bind
other proteins tend to be expressed in great abundance (30). However, transcription factors or
other regulators tend to be expressed in low abundance. Our protein is expressed in the bottom
10 to 25% of total proteins expressed in a bacterium (Table 6). However, its homolog which is
known to bind RNA is expressed in the top 25% repeatedly (Table 6). Based on the microfluidics
data of S. pneumoniae, its only interactor is recombination protein F after being screened against
all proteins is only recF. Now these wells will contain both protein, cDNA, and RNA. Therefore,
I cannot be certain at which stage SSA_2372 regulates its expression. Nevertheless, when
dsDNA damage occurs in response to a high proton concentration without the presence or
functionality of SSA_2372, the growth rate and cell yield is diminish significantly. There is
another piece of information that suggests it is involved in the homologous recombination
pathway. In Y2H, it bound PTS system IIA component (Table 5). PTS system IIA component
whether cytosolic or membrane bound catalyzes the pathway that leads to the transcription and
later translation of catabolic proteins. RecF requires ATP in its recFOR pathway in order to load
recA to the dsDNA breaks. Therefore, it would make sense potentially that a protein involved in
regulating recF expression would also be involved in metabolism. Since SSA_2372 has two
binding domains that also increases the feasibility of it performing 2 functions (Table 3).
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Supplemental

Supplemental Figure 1. BHI Agar Plate (pH7) Pinned with Streptococcus sanguinis SK36
mutants. On these two plates, 95 mutants were pinned in quadruplicate, and the plate was
incubated at 37 °C under microaerophilic conditions for 48 hours.
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Supplemental Figure 2. Growth Curves of the S. sanguinis SK36 candidate mutants and
control mutants in BHI broth at pH 5.4. 96 well plates were inoculated in pH specific media,
and it was grown overnight under microaerophilic conditions. Optical density readings at 600nm
were recorded every 10 minutes.

R Code. Statistical Tests performed to determine statistical significance were performed
using R Studio and the following code.
Eleventh<-read.csv(file.choose(),header = TRUE)
Eleventh$X6y
Eleventh$X6oxac
sixy<-(Eleventh$X6y)
sixy
sixoxac<-(Eleventh$X6oxac)
Eleventh$X5point4y
Eleventh$X5point4oxac
fivefoury<-(Eleventh$X5point4y)
fivefoury
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fivefouroxac<-(Eleventh$X5point4oxac)
msixy<-mean(Eleventh$X6y)
msixoxac<-mean(Eleventh$X6oxac)
t.test(sixy, sixoxac, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level = 0.95)
t.test(fivefoury, fivefouroxac, alternative = c("two.sided"), mu = 0, paired = FALSE,
conf.level = 0.95)
thirdtwenty<-read.csv(file.choose(),header = TRUE)
thirdtwenty$X5pHoxac
t.test(thirdtwenty$X5pHoxac, thirdtwenty$X5pHybcj, alternative = c("two.sided"), mu = 0,
paired = FALSE, conf.level = 0.95)
t.test(thirdtwenty$X5.5pHoxac, thirdtwenty$X5.5pHybcj, alternative = c("two.sided"), mu =
0, paired = FALSE, conf.level = 0.95)
t.test(thirdtwenty$X6pHoxac, thirdtwenty$X6pHybcj, alternative = c("two.sided"), mu = 0,
paired = FALSE, conf.level = 0.95)
msixy
thirdtwenty$X6pHybcj
sixy
Ecoli<-read.csv(file.choose(),header = TRUE)
t.test(Ecoli$X7pHoxac, Ecoli$X7pHybcj, alternative = c("two.sided"), mu = 0, paired =
FALSE, conf.level = 0.95)
t.test(Ecoli$X6pHoxac, Ecoli$X6pHybcj, alternative = c("two.sided"), mu = 0, paired =
FALSE, conf.level = 0.95)
t.test(Ecoli$X5pHoxac, Ecoli$X5pHybcj, alternative = c("two.sided"), mu = 0, paired =
FALSE, conf.level = 0.95)
June<-read.csv(file.choose(),header = TRUE)
May<-read.csv(file.choose(), header=TRUE)
June$sixsk36
May$sixsk36
fourteen<-(June$six1480 + May$six1480)
meanfour<-((fourteen)/(2))
meanfour
twentythree<-(June$six2372+May$six2372)
meanthree<-((twentythree)/(2))
meanthree
sk36<-(June$sixsk36 + May$sixsk36)
meansk36<-((sk36)/(2))
t.test(meansk36, meanfour, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level =
0.95)
t.test(meansk36, meanthree, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level
= 0.95)
fifteen<-(June$six1507 + May$six1507)
meanfif<-((fifteen)/(2))
meanfif
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t.test(meansk36, meanfif, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level =
0.95)
t.test(meansk36, meanthree, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level
= 0.99)
t.test(meansk36, meanfour, alternative = c("two.sided"), mu = 0, paired = FALSE, conf.level =
0.99)
meansk36
June$sevenSK36
May$sevenSK36
SK36neutral<-(June$sevenSK36+May$sevenSK36)
meansk36neu<-((SK36neutral)/(2))
meansk36neu
June$seven1507
May$seven1507
fifneutral<-(June$seven1507+May$seven1507)
meanfifneu<-((fifneutral)/(2))
meanfifneu
June$seven2372
May$seven2372
twothreeneutral<-(June$seven2372+May$seven2372)
meantwothreeneu<-((twothreeneutral)/(2))
meantwothreeneu
Bacillus<-read.csv(file.choose(),header = TRUE)
Bacillus
t.test(Bacillus$X5.5pHbs168, Bacillus$X5.5pHbsx, alternative = c("two.sided"), mu = 0,
paired = FALSE, conf.level = 0.95)
t.test(Bacillus$X6pHbs168, Bacillus$X6pHbsx, alternative = c("two.sided"), mu = 0, paired =
FALSE, conf.level = 0.95)
t.test(Bacillus$X5pHbs168, Bacillus$X5pHbsx, alternative = c("two.sided"), mu = 0, paired =
FALSE, conf.level = 0.95)
t.test(Bacillus$X5pHbs168, Bacillus$X5pHbsx, alternative = c("two.sided"), mu = 0, paired =
FALSE, conf.level = 0.99)
t.test(Bacillus$X7pHbs168, Bacillus$X7pHbsx, alternative = c("two.sided"), mu = 0, paired =
FALSE, conf.level = 0.95)
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